Neutralizing activity of African lineage Zika virus immune sera towards Asian lineage.

[1]  Didier Musso,et al.  Zika Virus , 2020, Pathogens.

[2]  W. Messer,et al.  Potency and breadth of human primary ZIKV immune sera shows that Zika viruses cluster antigenically as a single serotype , 2020, PLoS neglected tropical diseases.

[3]  M. Zazzi,et al.  Zika Virus in West Africa: A Seroepidemiological Study between 2007 and 2012 , 2020, Viruses.

[4]  J. Garrett Morris,et al.  Strain-Dependent Activity of Zika Virus and Exposure History in Serological Diagnostics , 2020, Tropical medicine and infectious disease.

[5]  A. Ko,et al.  Zika Virus Infection - After the Pandemic. , 2019, The New England journal of medicine.

[6]  A. Kucharski,et al.  Zika seroprevalence declines and neutralizing antibodies wane in adults following outbreaks in French Polynesia and Fiji , 2020, eLife.

[7]  D. Gubler,et al.  History and Emergence of Zika Virus , 2017, The Journal of infectious diseases.

[8]  F. Rovida,et al.  Antibody-based assay discriminates Zika virus infection from other flaviviruses , 2017, Proceedings of the National Academy of Sciences.

[9]  K. Stiasny,et al.  The Antigenic Structure of Zika Virus and Its Relation to Other Flaviviruses: Implications for Infection and Immunoprophylaxis , 2017, Microbiology and Molecular Biology Reviews.

[10]  A. Perelson,et al.  Zika viral dynamics and shedding in rhesus and cynomolgus macaques , 2016, Nature Medicine.

[11]  M. Beltramello,et al.  Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infection , 2016, Science.

[12]  J. Mascola,et al.  Broadly Neutralizing Activity of Zika Virus-Immune Sera Identifies a Single Viral Serotype. , 2016, Cell reports.

[13]  Anavaj Sakuntabhai,et al.  Structural basis of potent Zika–dengue virus antibody cross-neutralization , 2016, Nature.

[14]  Richard G. Jarman,et al.  Vaccine Protection Against Zika Virus from Brazil , 2016, Nature.

[15]  D. O’Connor,et al.  Heterologous Protection against Asian Zika Virus Challenge in Rhesus Macaques , 2016, bioRxiv.

[16]  Mark Holodniy,et al.  Phylogeny of Zika Virus in Western Hemisphere, 2015 , 2016, Emerging infectious diseases.

[17]  Didier Musso,et al.  Zika Virus , 2016, Clinical Microbiology Reviews.

[18]  R. Adegbola,et al.  Antibody Persistence at 1 and 4 Years Following a Single Dose of MenAfriVac or Quadrivalent Polysaccharide Vaccine in Healthy Subjects Aged 2–29 Years , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[19]  Judith M. Fonville,et al.  Dengue viruses cluster antigenically but not as discrete serotypes , 2015, Science.

[20]  T. Pierson,et al.  The Type-Specific Neutralizing Antibody Response Elicited by a Dengue Vaccine Candidate Is Focused on Two Amino Acids of the Envelope Protein , 2013, PLoS pathogens.

[21]  Robert B. Tesh,et al.  Continued Evolution of West Nile Virus, Houston, Texas, USA, 2002–2012 , 2013, Emerging infectious diseases.

[22]  Michael S. Diamond,et al.  Structural Basis of Differential Neutralization of DENV-1 Genotypes by an Antibody that Recognizes a Cryptic Epitope , 2012, PLoS pathogens.

[23]  D. Focks,et al.  Dengue serotypes 1–4 exhibit unique host specificity in vitro , 2012 .

[24]  Robert B. Tesh,et al.  Genetic Characterization of Zika Virus Strains: Geographic Expansion of the Asian Lineage , 2012, PLoS neglected tropical diseases.

[25]  A. Barrett,et al.  Reduced avian virulence and viremia of West Nile virus isolates from Mexico and Texas. , 2011, The American journal of tropical medicine and hygiene.

[26]  D. Diop,et al.  Immunogenicity and safety of a meningococcal A conjugate vaccine in Africans. , 2011, The New England journal of medicine.

[27]  M. Préziosi,et al.  The Meningitis Vaccine Project. , 2007, Vaccine.

[28]  G. Dick,et al.  Zika virus. I. Isolations and serological specificity. , 1952, Transactions of the Royal Society of Tropical Medicine and Hygiene.